Search - tctmd.com

Displaying 301 - 320 of 324

Sort: Relevancy | Date

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Daily News

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

L.A. McKeown

July 05, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

News Daily News

Morbid Obesity: An Increasing Risk Factor in PCI Patients

L.A. McKeown

June 20, 2013

News Daily News

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

Jason Kahn

April 12, 2013

News Daily News

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Caitlin E. Cox

April 05, 2013

News Industry News

World’s First Pulmonary Embolism Trial Comparing Endovascular Therapy to Standard of Care

March 08, 2013

News Conference News ACC 2013

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

L.A. McKeown

March 08, 2013

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Daily News

CT Scans Cause Delays in Care When Performed Prior to Primary PCI

Jason Kahn

May 04, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News ISET 2012

Jugular Angioplasty for MS May Improve Perceived Quality of Life

L.A. McKeown

March 21, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Yael L. Maxwell

December 12, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

Advertisement

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

Morbid Obesity: An Increasing Risk Factor in PCI Patients

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

Danish Registry: Dabigatran Safe, Effective in Real-World Use

World’s First Pulmonary Embolism Trial Comparing Endovascular Therapy to Standard of Care

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

Endovascular Therapy for DVT Appears Safe, Effective in Registries

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

CT Scans Cause Delays in Care When Performed Prior to Primary PCI

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Jugular Angioplasty for MS May Improve Perceived Quality of Life

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content